Azithromycin for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis: A Randomized Controlled Crossover Trial-Reference-Cited by-同舟云学术

Azithromycin for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis: A Randomized Controlled Crossover Trial

Published:2021-12 Issue:12 Volume:18 Page:2018-2026
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Guler Sabina A.¹^ORCID,Clarenbach Christian²,Brutsche Martin³,Hostettler Katrin⁴,Brill Anne-Kathrin¹,Schertel Anke¹,Geiser Thomas K.¹,Funke-Chambour Manuela¹^ORCID

Affiliation:

1. Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;

2. Department of Pulmonary Medicine, University Hospital of Zürich, Zürich, Switzerland;

3. Department of Pulmonary Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland; and

4. Clinics of Respiratory Medicine, University Hospital of Basel, Basel, Switzerland

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference52 articles.

1. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

2. Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013

3. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis

4. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives

5. Cough predicts prognosis in idiopathic pulmonary fibrosis

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis;Pharmaceutical Science Advances;2024-12

2. The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis;Respiratory Research;2024-08-27

3. The Effect of Long-Term Azithromycin on Objective and Subjective Cough in Chronic Respiratory Disease: A Systematic Review and Meta-analysis of Randomised Controlled Trials and Noncomparative Studies;Lung;2024-07-11

4. Application of Microbiome-Based Therapies in Chronic Respiratory Diseases;Journal of Microbiology;2024-03

5. OM85 ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting Notch expression and modulating the Th1/Th2 balance;2024-01-30